Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-14

Clinical Trial Update: Efficacy of Isradipine in Early Parkinson Disease [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy of isradipine in early Parkinson disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isradipine (isradipine)

Snippet

Sponsor: University of Rochester | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-01-14